Literature DB >> 23275727

Molecule of the month: HIV-1 protein Vpr and miRNA.

Paul Shapshak1.   

Abstract

Entities:  

Year:  2012        PMID: 23275727      PMCID: PMC3532007          DOI: 10.6026/97320630081243

Source DB:  PubMed          Journal:  Bioinformation        ISSN: 0973-2063


× No keyword cloud information.
miRNAs are a well-established RNA phenomenon. Previously, we analyzed the involvement of HIV-1 protein Tat in cellular gene networks and aspects of its interaction with miRNAs [1]. Here we mention an additional HIV-1 protein, HIV-1 viral protein R (Vpr) that interacts with miRNAs and it is involved in gene expression networks. The manipulation of miRNA expression is anticipated to become important in the attack on disease. miRNAs are generally derived from non-coding portions of the human genome and are intricately involved in gene expression control [2]. Moreover, it is estimated that although 1% of human genes are miRNAs, these miRNAs are involved in the control of gene expression of 10% of all the genes [3]. HIV-1 modifies the miRNA profile of infected cells. On the one hand, HIV-1 infection suppresses miRNAs that promote proteins that interfere with HIV-1 replication. Contemporaneously, on the other hand, HIV-1 enhances miRNAs that promote proteins that are beneficial for the replication of HIV-1 [4]. There are diverse effects on cells and tissues due to HIV-1 infection. For example, HIV-1-infected individuals often undergo pathological brain changes that result in disorders of cognition. Neuronal dysfunction is a hallmark of such pathologies. Proteins released from HIV-1- infected cells are associated with such dysfunction and HIV-1 Vpr is one such protein [5]. HIV-1 Vpr exhibits complex functions during HIV-1 replication and is involved in viral replication, shuttling between the infected cell’s nucleus and cytoplasm [6]. In neuron culture, in vitro, exposure to Vpr results in several adverse changes including v- synaptic retraction, mitochondrial dysfunction, oxidative stress pathway activation, expression of inflammatory molecules including cytokines, calcium homeostasis dysregulation, and calcium release from endoplasmic reticulum. Vpr dysregulates miRNAs including miR-34a as well as the miRNA target genes IRBIT, SERP1, SIRT1, NEFM, Drp-1, Orai, STIM1, IP3R, and CREB [5]. It should be noted that in the GNCPro database, Drp-1 maps to three genes CRMP1, DAPK2, and UTRN. Similarly, the gene IP3R maps to two genes ITPR1 and ITPR3 [7]. The proteins affected by miRNA-34a are identified as and include IRBIT - inositol 1,4,5-trisphosphate (IP3) receptor-binding protein; AHCYL1 - adenosyl-homocysteinase-like 1; SERP1 - stress associated endoplasmic reticulum protein 1; SIRT1 - sirtuin 1; NEFM - neurofilament, medium polypeptide; Drp-1 - dystrophin related protein 1/utrophin; CRMP1 - collapsin response mediator protein 1; DAPK2 - death-associated protein kinase 1; UTRN -utropin; ITPR1 - inositol 1,4,5-trisphosphate receptor, type 1; IP3R - inositol 1,4,5-trisphosphate receptor, type 3; ITPR3 - inositol 1,4,5-trisphosphate receptor, type 3; STIM1 - stromal interaction molecule 1; CREB - cAMP responsive element binding protein; and Orai - calcium releaseactivated calcium modulator [5, 7–9]. It should be noted that the Orai gene is absent from the GNCPro database. In addition, it should be noted that the terminology - semantics - is not fully consistent for a few of these proteins across all databases. As mentioned previously, a future analysis of semantics in the public databases will be done [10]. The figures illustrate various gene interactions among the proteins mentioned above. It is left as a puzzle for the interested reader to identify the various genes and their functions in Figure 1 & Figure 2 [7-9].
Figure 1

Network of input proteins and the input neighbors of these proteins. Consequent to HIV-1 infection, expression of these proteins may be modulated by miRNAs. In this figure, line-colors and various interactions with other genes are red Down-regulation, green Up-regulation, beige Regulation, purple Co-expression, brown Physical Interaction, turquoise dotted Predicted Protein Interaction, and mauve dotted Predicted TFactor Regulation (GenePro SA Biosciences, http://www.sabiosciences.com/).

Figure 2

Network of neighbor interactions of the input genes with the various networks through which they interact. Consequent to HIV-1 infection, expression of these proteins may be modulated by miRNAs. In this figure, line-colors and various interactions with other genes are red Down-regulation, green Up-regulation, beige Regulation, purple Co-expression, brown Physical Interaction, turquoise dotted Predicted Protein Interaction, and mauve dotted Predicted TFactor Regulation (GenePro SA Biosciences, http://www.sabiosciences.com/).

  5 in total

1.  Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.

Authors:  Ruma Mukerjee; J Robert Chang; Luis Del Valle; Asen Bagashev; Monika M Gayed; Randolph B Lyde; Brian J Hawkins; Eugen Brailoiu; Eric Cohen; Chris Power; S Ausim Azizi; Benjamin B Gelman; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 2.  Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis.

Authors:  Adriano Ferrucci; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

3.  Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition.

Authors:  Atze T Das; Thijn R Brummelkamp; Ellen M Westerhout; Monique Vink; Mandy Madiredjo; René Bernards; Ben Berkhout
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

4.  Molecule of the month HIV-1 Tat and miRNA.

Authors:  Paul Shapshak
Journal:  Bioinformation       Date:  2012-11-23

5.  Human MicroRNA targets.

Authors:  Bino John; Anton J Enright; Alexei Aravin; Thomas Tuschl; Chris Sander; Debora S Marks
Journal:  PLoS Biol       Date:  2004-10-05       Impact factor: 8.029

  5 in total
  3 in total

1.  HIV-1 Vpr suppresses expression of the thiazide-sensitive sodium chloride co-transporter in the distal convoluted tubule.

Authors:  Shashi Shrivastav; Hewang Lee; Koji Okamoto; Huiyan Lu; Teruhiko Yoshida; Khun Zaw Latt; Hidefumi Wakashin; James L T Dalgleish; Erik H Koritzinsky; Peng Xu; Laureano D Asico; Joon-Yong Chung; Stephen Hewitt; John J Gildea; Robin A Felder; Pedro A Jose; Avi Z Rosenberg; Mark A Knepper; Tomoshige Kino; Jeffrey B Kopp
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

2.  Molecule of the month: miRNA and HIV-1 TAR.

Authors:  Paul Shapshak
Journal:  Bioinformation       Date:  2013-01-18

3.  RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load.

Authors:  Palmiro Poltronieri; Binlian Sun; Massimo Mallardo
Journal:  Curr Genomics       Date:  2015-10       Impact factor: 2.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.